Key result
Marathon running is linked to a ~4% drop in exercise capacity alongside transient pulmonary inflammation.
Why the study?
Endurance exercise induces skeletal muscle, heart, and respiratory fatigue with morphofunctional cardiac changes and reduced maximal ventilation and oxygen consumption, but the relationship with exhaled nitric oxide and pulmonary inflammation after marathon is unclear.
Does running a marathon impair cardiopulmonary function and alter exhaled nitric oxide levels in male marathoners?
Observational (n=31)
Does running a marathon impair cardiopulmonary function and alter exhaled nitric oxide levels in male marathoners?
Marathon running induces acute pulmonary inflammation and transiently impairs cardiopulmonary capacity, which correlates with changes in exhaled nitric oxide bioavailability.
Answers are grounded in this paper and cite their sources.
May warrant caution in post-marathon recovery monitoring; hypothesis-generating for nitric oxide and inflammation effects, needing prospective validation.
Background. The endurance exercise is capable of inducing skeletal muscle, heart, and respiratory fatigue, evidenced by morphofunctional cardiac changes, release of myocardial injury biomarkers, and reduction of maximal voluntary ventilation and oxygen consumption (VO2) at peak exercise. Purpose. The aim of this study was to investigate whether marathoners present cardiac fatigue after marathon and whether it correlates with pulmonary levels of exhaled nitric oxide (eNO) and pulmonary inflammation. Methods. 31 male marathoners, age 39±9 years, were evaluated by cardiopulmonary exercise test three weeks before and between three and 15 days after a marathon; eNO analysis and spirometry were evaluated before, immediately after, and 24 and 72 hours after the marathon, and sputum cellularity and cytokine level were assessed before and after the marathon. Results. Marathon induced an increase in the percentage of macrophages, neutrophils (from 0.65% to 4.28% and 6.79% to 14.11%, respectively), and epithelial cells and a decrease in cytokines in induced sputum, followed by an increase in eNO concentration ( 20±11 to 35±19 ppb), which presented a significant reduction 24 and 72 hours after marathon ( 9±12 e 12±9 ppb, p<0.05 ). We observed a decrease in the spirometry parameters in all time points assessed after the marathon ( p<0.05 ) as well as in cardiopulmonary capacity, evidenced by a reduction in VO2 and ventilation peaks ( 57±6 to 55±6 mL·min-1·Kg-1 and 134±19 to 132±18 Lpm, respectively, p<0.05 ). Finally, we observed a negative correlation between the decrease in forced expiratory volume and decrease in eNO 24 and 72 hours after marathon ( r=−0.4 , p=0.05 ). Conclusion. Reduction in eNO bioavailability after marathon prevents the reduction in cardiopulmonary capacity induced by acute inflammatory pattern after marathon.
No takes yet. Share an insight, caveat, or question.
Sierra et al. (2019) conducted an observational in Healthy marathon runners (n=31). Marathon running vs. Pre-marathon baseline was evaluated on Cardiopulmonary capacity (peak VO2) and exhaled nitric oxide levels (p=<0.05). Marathon running reduced cardiopulmonary capacity, decreasing exercise capacity from 57 to 55 mL/min/kg, and induced transient changes in exhaled nitric oxide and pulmonary inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: